Brought to you by:
Start of PAD Awareness Month heralds joint national effort to prevent amputations
The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) dedicated to improving vascular health—is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD…
Imperative Care announces FDA clearance for Symphony thrombectomy system
Imperative Care has today announced Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE). This clearance expands the use of Symphony—previously for the treatment of venous thrombosis—to now include PE, providing a…
FDA begins ‘real-time’ reporting of adverse event data
The Food and Drug Administration (FDA) recently announced that it has begun daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). The agency says that “this represents a significant step forward in modernizing the agency’s…
SWEDEPAD re-opens paclitaxel safety discussion, finds drug-coated devices do not improve outcomes
Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials. In addition, higher five-year mortality with drug-coated devices in patients with intermittent…
Final patient treated in Cook’s Zenith Fenestrated+ endovascular graft clinical study
Cook Medical has enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study. The investigational ZFEN+ clinical study is being conducted under an Investigational Device Exemption…
Journal of Vascular Surgery secures new editor-in-chief
The Journal of Surgery (JVS) has appointed Audra Duncan, MD, of Western University in London, Ontario, Canada, as its new editor-in-chief. Duncan will lead the journal for a four-year term, renewable for two more years, following the decision of the…
Boston Scientific recalls Carotid Wallstent Monorail devices over ‘manufacturing defect’
Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis owing to a “manufacturing defect” that has led to devices having an inner lumen that is smaller than specifications, causing resistance when withdrawing the stent delivery system. A Food and Drug…
Pharmacologic treatment, follow-up in cessation services help drive abstinence in PAD patients
A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important…
AI: Where it lands today and how it might impact the vascular future
The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many as jarring. Its entrance into the world of vascular surgery, too, has picked up a pace in recent years, with models and…
Abbott’s Esprit BTK system receives CE mark
Abbott today announced it has received CE mark approval in Europe for the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a technology designed for the treatment of below-the-knee (BTK) peripheral arterial disease (PAD). Abbott notes that the Esprit…